Search by Drug Name or NDC
NDC 00067-8202-03 Excedrin 250; 250; 65 mg/1; mg/1; mg/1 Details
Excedrin 250; 250; 65 mg/1; mg/1; mg/1
Excedrin is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 00067-8202 |
|---|---|
| Product ID | 0067-8202_60acc110-03ee-44f1-9c51-f4bf0c92f688 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Excedrin |
| Proprietary Name Suffix | Extra Strength Pain Reliever |
| Non-Proprietary Name | Acetaminophen, Aspirin (NSAID), and Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00067-8202-03 (00067820203)
| NDC Package Code | 0067-8202-03 |
|---|---|
| Billing NDC | 00067820203 |
| Package | 1 BOTTLE in 1 CARTON (0067-8202-03) / 300 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2020-03-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |